Bone Void Articles & Analysis
14 news found
Schlieren (Zurich), Switzerland, April 27, 2022 – Kuros Biosciences (SIX: KURN), a leader in next generation bone graft technologies, today provided a first-quarter business update, showing a significant acceleration in product sales of its Medical devices segment. ...
Schlieren (Zurich), Switzerland, April 27, 2022 – Kuros Biosciences (SIX: KURN), a leader in next generation bone graft technologies, today provided a first-quarter business update, showing a significant acceleration in product sales of its Medical devices segment. ...
Schlieren (Zurich), Switzerland, April 27, 2022 – Kuros Biosciences (SIX: KURN), a leader in next generation bone graft technologies, today provided a first-quarter business update, showing a significant acceleration in product sales of its Medical devices segment. ...
Schlieren (Zurich), Switzerland, April 21, 2022 – Kuros Biosciences (“Kuros” or the “Company”), a leader in next generation bone graft technologies, announced today that its MagnetOs Flex Matrix has been cleared by the U.S. Food and Drug Administration (FDA) as a bone void filler for use in the posterolateral spine. ...
Effective July 1st, the new agreement allows Premier members, at their discretion, to take advantage of pricing and terms pre-negotiated by Premier for CERAMENT® BONE VOID FILLER. “The awarded contract by Premier is a strong testimony and confirmation of the unique value CERAMENT offers hospitals, surgeons and patients. This agreement will further ...
Currently, the standard treatment for chronic osteomyelitis is surgical debridement, long-term, high-dose administration of antibiotics, and – for larger defects – bone grafting which often requires a second surgical procedure to remove the non-resorbable bone graft. CognitOss is intended to offer surgeons a single surgical procedure alternative, ...
GRAFTYS SA (“Graftys”), a global leader in resorbable bone cements, is proud to announce that as a fruitful result of 10 years’ partnership with its distributor - LAS Brasil, the milestone of 10,000 units of GRAFTYS® HBS sold in Brazil has been crossed during the third quarter of 2020. GRAFTYS® HBS is a calcium phosphate bone graft substitute, which offers very low ...
ByGraftys
The contract will enable NuShores to develop intelligent automated production of its NuCress™ bone void filler scaffold products using its “factory in a box” concept. ...
GRAFTYS SA (“Graftys”), a global leader in resorbable bone cements, is pleased to announce the CE recertification in Europe and the certification of its Quality Management System in conformity with the Medical Device Single Audit Program (MDSAP) in Australia, Brazil, Canada and the United States of America for the Design, Manufacture and Distribution of its Sterile ...
ByGraftys
UA Little Rock has received Army Medical Command approval to contract with NuShores to perform first generation production development of the NuCressTM bone regenerative product line. Little Rock, AR – The University of Arkansas at Little Rock has received state and federal approval to award a services contract to NuShores Biosciences LLC (NuShores) for Generation 1 ...
He will lead NuShores Generation 1 manufacturing of NuCress™ bone void filler scaffold products and serve as the Program Director and Principal Investigator on new and pending manufacturing projects to automate the company’s production systems. ...
Various types of bone graft substitutes such as collagen, demineralized bone matrix, xenograft, artificial bone, and growth factor products are available, but none of these products are more effective than the gold-standard, autologous bone graft. ...
Pinnacle Spine Group, LLC, a developer of innovative spinal fusion solutions engineered to deliver optimal bone graft volume and graft-to-endplate contact, today announced the launch of its InFill® V2 Lateral Interbody Device. ...
According to the EC's request, in the field of medical devices, the following cases of alleged use of nanomaterials have been identified by Notified Bodies: Carbon nanotubes in bone cements; Nanopaste hydroyapatite powder for bone void filling; Polymer setting material with nanoparticles in dental cements; Polycrystalline nanoceramics in ...